Pittman, the United States District Judge for the Northern District of Texas Fort Worth Division, ordered an expedited hearing of the matter to take place January 14, 2025
[1] [2] As a medication containing a peptide structure, tirzepatide requires specific storage conditions to maintain its stability, potency, and safety profile
Name brands such as Mounjaro and Zepbound that contain tirzepatide are far more likely to be covered by your insurance than the compounded version
The litigations further allege that manufacturers failed to adequately warn patients and prescribing physicians about potential risks associated with these drugs despite emerging safety reports, adverse event data, and growing medical concern surrounding gastrointestinal and optic nerve injuries
The medication has shown promising results in clinical trials, where clients experienced a noticeable reduction in body weight and better overall metabolic function